XPH - SPDR S&P Pharmaceuticals ETF

Description: The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is an equal weighted market cap index.

Last Updated:

XPH - Profile


Summary Data for XPH

52 Week Lo: $72.63 52 Week Hi: $106.76
AUM: $897.6 M Shares: 8.9 M
Avg. Volume (1 month) 77,946 Avg. Volume (3 month) 85,803
Filings Data as of:

XPH - Holdings

Top Ten Holdings

  1. Akorn Inc AKRX: 4.21%
  2. Salix Pharmaceuticals Ltd SLXP: 4.05%
  3. Pacira Pharmaceuticals Inc PCRX: 3.86%
  4. Hospira Inc HSP: 3.76%
  5. Bristol-Myers Squibb Company BMY: 3.70%
  6. Perrigo Co PLC PRGO: 3.69%
  7. Eli Lilly and Co LLY: 3.57%
  8. Allergan Inc AGN: 3.53%
  9. Actavis PLC ACT: 3.53%
  10. Zoetis Inc ZTS: 3.53%
%Assets in Top 10: 37.42%
Total Holdings: 34.0

XPH Asset Allocation


Asset Percentage
U.S. Stocks 92.66%
International Stocks 7.22%
U.S. Bonds 0.0%
International Bonds 0.0%
Preferred Stock 0.0%
Convertibles 0.0%
Cash 0.12%
Other 0.0%

XPH Sector Breakdown


Sector Percentage
Health Care 99.88%
Financial Services 0.0%
Communication Services 0.0%
Consumer Defensive 0.0%
Real Estate 0.0%
Industrials 0.0%
Consumer Cyclical 0.0%
Basic Materials 0.0%
Energy 0.0%
Technology 0.0%
Utilities 0.0%

XPH Market Cap Breakdown


Market Cap Percentage
Giant 20.66%
Large 17.66%
Medium 21.2%
Small 24.13%
Micro 16.23%

XPH Region Breakdown


Region Percentage
U.S. 92.66%
Europe 7.22%
Middle East 0.0%
Japan 0.0%
Australia 0.0%
Africa 0.0%
Asia (Developed) 0.0%
Latin America 0.0%
Canada 0.0%
Asia (Emerging) 0.0%
Region Percentage
Developed 99.88%
Emerging 0.0%

XPH Country Breakdown


Country Percentage
United States 92.66%
Ireland 7.22%
Other 0.12%
© 2014 Morningstar Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

XPH - Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the PDF
It appears you don't have Adobe Reader or PDF support in this web browser. Click here to download the PDF

Having trouble viewing?
Visit Adobe.com to install Adobe Acrobat Viewer.

XPH - Charts

The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.

The following chart also includes the option to compare the performance of XPH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.

XPH - Fundamentals

XPH Performance

1 Week Return: 2.73%
2 Week Return: 5.98%
4 Week Return: 0.78%
13 Week Return: 4.07%
26 Week Return: 0.90%
YTD Return: 14.58%
1 Year Return: 36.43%
3 Year Return: 140.96%
5 Year Return: 230.15%

XPH Expenses & Fees

XPH Valuation

P/E Ratio: 19.92
Beta: -1.83
20 Day Moving Average: $97.21
60 Day Moving Average: $99.92

XPH Dividend

Annual Dividend Rate: $1.82
Dividend Date: 2014-06-20
Dividend: $0.14
Annual Dividend Yield %: 1.80%

XPH Volatility

5 Day Volatility: 42.18%
20 Day Volatility: 17.21%
50 Day Volatility: 16.87%
200 Day Volatility: 18.70%
Standard Deviation: 9.11%

XPH - Technicals

XPH Technicals

20 Day MA: $97.21
60 Day MA: $99.92
MACD 15 Period: 3.22
MACD 100 Period: 3.06
Williams % Range 10 Day: 8.97
Williams % Range 20 Day: 7.30
RSI 10 Day: 65
RSI 20 Day: 56
RSI 30 Day: 54
Ultimate Oscillator: 71

XPH Bollinger Bands

Lower Bollinger (10 Day): $93.95
Upper Bollinger (10 Day): $102.12
Lower Bollinger (20 Day): $93.38
Upper Bollinger (20 Day): $100.92
Lower Bollinger (30 Day): $93.57
Upper Bollinger (30 Day): $103.04

XPH Support & Resistance

Support Level 1: $100.16
Support Level 2: $99.79
Resistance Level 1: $101.02
Resistance Level 2: $101.51

XPH Stochastic

Stochastic Oscillator %D (1 Day): 60.64
Stochastic Oscillator %D (5 Day): 88.66
Stochastic Oscillator %K (1 Day): 68.57
Stochastic Oscillator %K (5 Day): 85.41

XPH Volatility

5 Day Volatility: 42.18%
20 Day Volatility: 17.21%
50 Day Volatility: 16.87%
200 Day Volatility: 18.70%
Standard Deviation: 9.11%

XPH - ETFdb Realtime Rating & Analyst Report

XPH is a passive ETF that seeks to replicate S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is an equal weighted market cap index.

ETFdb Category Expense Ratio Inception Date Issuer Structure YTD Return *
Health & Biotech Equities 0.35 2006-06-19 State Street SPDR ETF +14.58%

XPH Realtime Rating: By Metric

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B
Expenses B+
Performance ETFdb Pro Members Only
Volatility ETFdb Pro Members Only
Dividend ETFdb Pro Members Only
Concentration ETFdb Pro Members Only

The first adjacent table gives investors an individual Realtime Rating for XPH on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.

XPH Realtime Rating: Overall

ETFdb Rating Type Overall Rating A+ Overall Rated ETF
Realtime Rating (Overall) ETFdb Pro Members Only ETFdb Pro Members Only

The second table shows the overall Realtime Rating for XPH, as well as the A+ Overall Rated ETF in XPH's Category. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

ETFdb Analyst Report for XPH

This ETF is one of several options for investors looking to establish exposure to the U.S. pharmaceutical industry, a sub-sector of the health care space that can post big returns during periods of consolidation or as a result of advancements in medicine. Given this narrow focus, XPH probably doe...

Pro Membership Required to Continue Reading ETFdb Pro Members Only

To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 14-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:

  • Register on ETFdb Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.
  • Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
  • Get access to our premium monthly newsletter ETF Edge.
  • Gain access to premium research reports covering popular sectors of the ETF industry.
  • Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
  • Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
  • Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.

Begin Your Free 14-Day Trial Now - or - Read more about ETFdb Pro

Latest XPH News Stories

Search ETF Database

Enter a ticker symbol or keyword: